Additional file 2: of Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)
journal contributionposted on 10.08.2019 by Joseph Muenzer, Roberto Giugliani, Maurizio Scarpa, Anna Tylki-SzymaĹska, Virginie Jego, Michael Beck
Any type of content formally published in an academic journal, usually following a peer-review process.
Table S2. Median urinary glycosaminoglycan (uGAG) levels and median changes from baseline in uGAG levels in patients with data available at consecutive timepoints (year 1, year 2 and year 3 of treatment with idursulfase) (DOCX 22 kb)